ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

John Niederhuber Named Acting NCI Director.

June 2, 2006

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR

May 4, 1979

In Brief: Forget Hew – It’s No HHS; Cancer Control Advisory Committee Meeting Set For Oct. 22

October 5, 1979